Kantata Releases New Enhancements Purpose-built for Professional Services Organizations
A new integration with Salesforce Revenue Cloud provides features and capabilities that empower business leaders…
A new integration with Salesforce Revenue Cloud provides features and capabilities that empower business leaders…
− Fibrosis regression observed in 50% of patients receiving fazirsiran − Median reductions of 94%…
DALLAS–(BUSINESS WIRE)–Today, Worlds Enterprises, Inc., creators of a new 4D infrastructure for building the Industrial…
Prior Roles Include Senior Leadership Positions Demonstrating Revenue Growth, Tech Innovation, and Product Development on…
TEMPLE, GA–(BUSINESS WIRE)–Janus International Group, Inc. (NYSE: JBI) (“Janus” or the “Company”), a leading provider…
Guzman Energy will continue delivering wholesale power savings to KCEC; savings estimated between $150-170 million…
Study met both co-primary endpoints with robust immune responses COVAXIN™ was found to be well-tolerated…
MARTINSRIED, Germany and MUNICH, Germany, Jan. 09, 2023 (GLOBE NEWSWIRE) — Proteros biostructures GmbH, a…
Internet City, Dubai–(Newsfile Corp. – January 9, 2023) – LBank Exchange, a global digital asset…
Brooklyn, New York–(Newsfile Corp. – January 9, 2023) – Bruder Office Furniture is pleased to…
Internet City, Dubai–(Newsfile Corp. – January 9, 2023) – LBank Exchange, a global digital asset…
The Medical Director of Medicaid Cancer Foundation H.E Dr. Zainab Shinkafi Bagudu has expressed her…
HONG KONG, Jan 9, 2023 – (ACN Newswire) – As the first round of Hong…
Bloom and Telam to team on distributed power and electrolyzer deployment opportunities, supporting the electrification…
BOSTON–(BUSINESS WIRE)–Privacy Wizards, a website dedicated to online privacy and cyber security, has published their…
— Certification expands Viralgen’s capacity threefold and positions the company as a world-leading CDMO —…
Viralgen receives cGMP certification to produce rAAV commercial grade product at new facility in San…
WALTHAM, Mass., Jan. 09, 2023 (GLOBE NEWSWIRE) — CinCor Pharma, Inc. (NASDAQ: CINC) today announced…
PRESS RELEASE STALICLA signs exclusive in-licensing agreement for late-stage clinical neuropsychiatric and neurodevelopmental disorder treatment…
First-in-kind Singapore study to deliver insights into heart disease, diabetes, cancer, and other chronic diseases…